Grace Therapeutics, Inc. SEC filings GRCE

Grace Therapeutics, Inc. has 594 filings in SEC EDGAR's recent list, going back to Sep 2, 2008. Its latest annual report, Form 10-K, was filed on Jun 18, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 18, 2026 (shareholder vote results). The company's fiscal year ends on March 31.

Grace Therapeutics, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Nov 5, 2026 Nov 3, 2026
4 Insider transaction Oct 26, 2026 Oct 22, 2026
4 Insider transaction Oct 21, 2026 Oct 19, 2026
4 Insider transaction Oct 16, 2026 Oct 14, 2026
4 Insider transaction Oct 13, 2026 Oct 8, 2026
4 Insider transaction Oct 5, 2026 Oct 1, 2026
4 Insider transaction Oct 1, 2026 Sep 29, 2026
4/A Filing Oct 1, 2026 Sep 21, 2026
4 Insider transaction Sep 23, 2026 Sep 21, 2026
4 Insider transaction Sep 21, 2026 Sep 17, 2026
4 Insider transaction Sep 21, 2026 Sep 17, 2026
4 Insider transaction Sep 21, 2026 Sep 17, 2026
4 Insider transaction Sep 21, 2026 Sep 17, 2026
8-K Current report
Shareholder vote results
Sep 18, 2026 Sep 17, 2026
4 Insider transaction Sep 10, 2026 Sep 8, 2026
4 Insider transaction Sep 10, 2026 Sep 9, 2026
4 Insider transaction Sep 1, 2026 Aug 28, 2026
4 Insider transaction Sep 1, 2026 Aug 28, 2026
4 Insider transaction Sep 1, 2026 Aug 28, 2026
4 Insider transaction Sep 1, 2026 Aug 28, 2026
EFFECT Filing Aug 31, 2026 —
S-3 Shelf registration Aug 24, 2026 —
4 Insider transaction Aug 19, 2026 Aug 14, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
D Filing Aug 11, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 7, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 6, 2026 Aug 4, 2026
DEFA14A Additional proxy material Jul 28, 2026 —
DEF 14A Proxy statement Jul 28, 2026 Sep 17, 2026
8-K Current report
Other events
Jul 28, 2026 Jul 28, 2026
8-K Current report
Other events
Jun 18, 2026 Jun 18, 2026
8-K Current report
Results of operations
Jun 18, 2026 Jun 18, 2026
10-K Annual report Jun 18, 2026 Mar 31, 2026
8-K Current report
Officer or director change
Jun 5, 2026 Jun 1, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 27, 2026 —
8-K Current report
Other events
Apr 27, 2026 Apr 27, 2026
8-K Current report
Other events
Apr 23, 2026 Apr 23, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
8-K Current report
Results of operations
Feb 12, 2026 Feb 12, 2026
10-Q Quarterly report Feb 12, 2026 Dec 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 28, 2026 —
8-K Current report
Officer or director change
Jan 12, 2026 Jan 10, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
10-Q/A Amended quarterly report Nov 17, 2025 Sep 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
8-K Current report
Results of operations, Other events
Nov 13, 2025 Nov 13, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Other events
Oct 23, 2025 Oct 23, 2025
8-K Current report
Other events
Sep 18, 2025 Sep 18, 2025
8-K Current report
Shareholder vote results
Sep 12, 2025 Sep 12, 2025
8-K Current report
Other events
Aug 27, 2025 Aug 27, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
8-K Current report
Results of operations
Aug 12, 2025 Aug 12, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
DEFA14A Additional proxy material Jul 28, 2025 —
DEF 14A Proxy statement Jul 28, 2025 Sep 12, 2025
8-K Current report
Other events
Jun 25, 2025 Jun 25, 2025
8-K Current report
Results of operations
Jun 23, 2025 Jun 23, 2025
10-K Annual report Jun 23, 2025 Mar 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2025 —
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 8, 2025 —
4 Insider transaction Apr 16, 2025 Apr 14, 2025
4 Insider transaction Apr 16, 2025 Apr 14, 2025
4 Insider transaction Apr 16, 2025 Apr 14, 2025
4 Insider transaction Apr 16, 2025 Apr 14, 2025
4 Insider transaction Apr 16, 2025 Apr 14, 2025
8-K Current report
Other events
Apr 9, 2025 Apr 9, 2025
EFFECT Filing Mar 13, 2025 —
CORRESP Letter to the SEC Mar 12, 2025 —
UPLOAD Letter from the SEC Mar 11, 2025 —
S-3 Shelf registration Mar 10, 2025 —
8-K Current report
Other events
Mar 3, 2025 Mar 3, 2025
D Filing Feb 25, 2025 —
10-Q/A Amended quarterly report Feb 19, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 13, 2025 Feb 13, 2025
10-Q Quarterly report Feb 13, 2025 Dec 31, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Feb 10, 2025 Feb 10, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 29, 2025 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Bylaw or fiscal year change
Oct 28, 2024 Oct 24, 2024
8-K Current report
Other events
Oct 25, 2024 Oct 25, 2024
EFFECT Filing Oct 15, 2024 —
EFFECT Filing Oct 15, 2024 —
S-8 Employee stock plan registration Oct 8, 2024 —
S-8 POS Filing Oct 8, 2024 —
S-8 POS Filing Oct 8, 2024 —
S-8 POS Filing Oct 8, 2024 —
POS AM Filing Oct 8, 2024 —
POS AM Filing Oct 8, 2024 —
8-K Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change
Oct 7, 2024 Oct 1, 2024
8-K Current report
Officer or director change, Shareholder vote results
Sep 30, 2024 Sep 30, 2024
8-K Current report
Other events
Sep 25, 2024 Sep 25, 2024
DEFA14A Additional proxy material Sep 6, 2024 —
8-K Current report
Officer or director change
Aug 16, 2024 Aug 12, 2024
8-K Current report
Results of operations
Aug 9, 2024 Aug 9, 2024
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
DEFA14A Additional proxy material Aug 7, 2024 —
424B3 Prospectus Aug 7, 2024 —
EFFECT Filing Aug 2, 2024 —
CORRESP Letter to the SEC Jul 31, 2024 —
S-4/A Filing Jul 31, 2024 —
3/A Primary document Jul 11, 2024 Jun 28, 2024
SC 13G Ownership over 5% (passive) Jul 10, 2024 —
3 Initial insider ownership Jul 9, 2024 Jun 28, 2024
UPLOAD Letter from the SEC Jul 3, 2024 —
S-4 Registration for a merger or exchange Jun 27, 2024 —
8-K Current report
Other events
Jun 27, 2024 Jun 27, 2024
8-K Current report
Results of operations
Jun 21, 2024 Jun 21, 2024
10-K Annual report Jun 21, 2024 Mar 31, 2024
4/A Filing May 10, 2024 May 6, 2024
4/A Filing May 10, 2024 May 6, 2024
4 Insider transaction May 8, 2024 May 6, 2024
4 Insider transaction May 8, 2024 May 6, 2024
4 Insider transaction May 8, 2024 May 6, 2024
4 Insider transaction May 8, 2024 May 6, 2024
4 Insider transaction May 8, 2024 May 6, 2024
SC 13G Ownership over 5% (passive) Apr 9, 2024 —
8-K Current report
Regulation FD disclosure
Apr 1, 2024 Apr 1, 2024
SC 13G Ownership over 5% (passive) Feb 13, 2024 —
8-K Current report
Results of operations
Feb 12, 2024 Feb 12, 2024
10-Q Quarterly report Feb 12, 2024 Dec 31, 2023
3 Initial insider ownership Jan 8, 2024 Jan 5, 2024
8-K Current report
Officer or director change
Jan 8, 2024 Jan 5, 2024
4 Insider transaction Dec 20, 2023 Dec 19, 2023
4 Insider transaction Dec 20, 2023 Dec 19, 2023
4 Insider transaction Dec 20, 2023 Dec 19, 2023
4 Insider transaction Dec 20, 2023 Dec 19, 2023
4 Insider transaction Dec 20, 2023 Dec 19, 2023
8-K Current report
Auditor change
Dec 15, 2023 Dec 11, 2023
8-K Current report
Results of operations
Nov 13, 2023 Nov 13, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Material agreement, Other events
Oct 23, 2023 Oct 18, 2023
3 Initial insider ownership Oct 20, 2023 Oct 10, 2023
3 Initial insider ownership Oct 20, 2023 Oct 10, 2023
3 Initial insider ownership Oct 20, 2023 Oct 10, 2023
EFFECT Filing Oct 16, 2023 —
424B3 Prospectus Oct 16, 2023 —
CORRESP Letter to the SEC Oct 12, 2023 —
UPLOAD Letter from the SEC Oct 12, 2023 —
8-K Current report
Shareholder vote results
Oct 11, 2023 Oct 10, 2023
D Filing Oct 10, 2023 —
S-3 Shelf registration Oct 6, 2023 —
4 Insider transaction Sep 27, 2023 Sep 25, 2023
8-K Current report
Material agreement, Unregistered share sale, Other events
Sep 26, 2023 Sep 24, 2023
4 Insider transaction Sep 5, 2023 Aug 31, 2023
S-8 Employee stock plan registration Aug 25, 2023 —
DEFA14A Additional proxy material Aug 25, 2023 —
DEF 14A Proxy statement Aug 25, 2023 Oct 10, 2023
8-K Current report
Results of operations
Aug 11, 2023 Aug 11, 2023
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
8-K Current report
Other events
Jul 24, 2023 Jul 24, 2023
4 Insider transaction Jul 18, 2023 Jul 14, 2023
4 Insider transaction Jul 18, 2023 Jul 14, 2023
4 Insider transaction Jul 18, 2023 Jul 14, 2023
4 Insider transaction Jul 18, 2023 Jul 14, 2023
4 Insider transaction Jul 18, 2023 Jul 14, 2023
4 Insider transaction Jul 18, 2023 Jul 14, 2023
4 Insider transaction Jul 18, 2023 Jul 14, 2023
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Jul 7, 2023 Jul 4, 2023
8-K Current report
Other events
Jul 5, 2023 Jul 5, 2023
8-K Current report
Results of operations
Jun 23, 2023 Jun 23, 2023
10-K Annual report Jun 23, 2023 Mar 31, 2023
3 Initial insider ownership May 26, 2023 May 8, 2023
3 Initial insider ownership May 18, 2023 May 8, 2023
3 Initial insider ownership May 18, 2023 May 8, 2023
8-K Current report
Officer or director change, Other events
May 11, 2023 May 8, 2023
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Apr 5, 2023 Apr 4, 2023
8-K Current report
Officer or director change
Mar 31, 2023 Mar 30, 2023
8-K Current report
Regulation FD disclosure, Other events
Mar 13, 2023 Mar 13, 2023
8-K Current report
Auditor change
Feb 23, 2023 Feb 22, 2023
8-K Current report
Results of operations
Feb 14, 2023 Feb 14, 2023
10-Q Quarterly report Feb 14, 2023 Dec 31, 2022
8-K Current report
Other events
Jan 25, 2023 Jan 25, 2023
8-K Current report
Other events
Dec 28, 2022 Dec 28, 2022
8-K Current report
Other events
Dec 22, 2022 Dec 22, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
4 Insider transaction Sep 30, 2022 Sep 28, 2022
4 Insider transaction Sep 30, 2022 Sep 28, 2022
4 Insider transaction Sep 30, 2022 Sep 28, 2022
4 Insider transaction Sep 30, 2022 Sep 28, 2022
8-K Current report
Other events
Sep 30, 2022 Sep 30, 2022
8-K Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
Sep 29, 2022 Sep 28, 2022
3 Initial insider ownership Sep 16, 2022 Sep 9, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
GRCE (Nasdaq)
Fiscal year ends
March 31
Incorporated in
DE
Headquarters
Princeton, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1444192
Former names
Acasti Pharma Inc. (until Oct 25, 2024)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.